MicroRNA ۲۱۰ as a Biomarker in Breast Cancer
Publish place: Personalized Medicine Journal، Vol: 5، Issue: 19
Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 184
متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_PMJ-5-19_004
تاریخ نمایه سازی: 11 خرداد 1400
Abstract:
The increasing literature exploring the role of circulating miR-۲۱۰ has clarified its potential as a promising biomarker for early detection, diagnosis and prognosis. Measuring circulating miR-۲۱۰ levels could be a non-invasive method for early cancer detection. Even if, to date, most studies appear to be preliminary it seems that miR-۲۱۰ will be a good target for drug development. In this study, we had detected the difference of serum miR-۲۱۰ expression between health and breast cancer patients. total of ۱۵ breast cancer patients were selected for the breast cancer (BC) group and ۱۵ healthy people. The results showed The expression level of miR-۲۱۰ in the serum of breast cancer patients was significantly higher compared with that in healthy individuals. Patients with breast cancer present increased levels of circulating miR-۲۱۰; thus, circulating miR-۲۱۰ may be a potential biomarker of tumor presence and therapeutic response in breast cancer
Keywords:
Authors
Mohamad AlJarallah
Jarallah German Specialized Clinic
Nafise Poorhasan
Department of Cellular and Molecular, Faculty of Life Sciences, North Tehran Branch, Islamic Azad University, Faculty of Biological Sciences, Tehran, Iran